RxDoctor Payments Data

Rimal Bera, MD

Psychiatry · Orange, CANPI 1578643656

Payments from drug & device makers

$137,578in general payments, 2019–2025

Across 593 payments — averaging $232.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$31K
  • Sunovion Pharmaceuticals Inc.$18K
  • Teva Pharmaceuticals USA, Inc.$18K
  • Axsome Therapeutics, Inc.$16K
  • Neurocrine Biosciences, Inc.$14K
  • E.r. Squibb & Sons, L.L.C.$11K
  • plus $30K from 21 others
$2,115in research payments, 2019–2025

Across 2 payments — averaging $1057.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Biogen$2K
  • Avanir Pharmaceuticals, Inc.$375

What the payments were for

  • Consulting fees$64,27447%
  • Speaking & faculty fees$47,26034%
  • Travel & lodging$13,23610%
  • Food & beverage$12,7639%
  • Education$460%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$137,578 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Medicare billing

Part B allowed, 2024
$39,755
Medicare patients
183
Services billed
416

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate97$270,351
VraylarCariprazine Hcl119$190,768
Abilify MaintenaAripiprazole68$169,389
CaplytaLumateperone Tosylate55$105,893
RexultiBrexpiprazole18$48,064
Clozapine450$32,101
FanaptIloperidone16$29,756
Aripiprazole434$25,916
TrintellixVortioxetine Hydrobromide37$20,378
Lurasidone Hcl55$18,920
NuedextaDextromethorphan Hbr/Quinidine11$18,169
Divalproex Sodium ErDivalproex Sodium354$13,120
CymbaltaDuloxetine Hcl27$12,671
Quetiapine Fumarate662$12,365
Paliperidone ErPaliperidone73$9,495

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$7,834$270,35197 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$31,112$217,45386 claims
AbbVieVraylar$889$190,768119 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$1,971$105,89355 claims
Vanda Pharmaceuticals Inc.Fanapt$259$29,75616 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$43$20,37837 claims
Avanir Pharmaceuticals, Inc.Nuedexta$42$18,16911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,954 psychiatry providers in California.

Other psychiatry in Orange

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →